The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd, by
, the filing said.
The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.
The IPO will be subject to market conditions, receipt of applicable approvals and other considerations, the filing said.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor.